
FlorezLab/X
Jun 6, 2025, 01:31
Abner Antonio Murray: Duaa Kanan’s Groundbreaking AI Pipeline for NSCLC Therapy at ASCO25
Abner Antonio Murray, Hematology/Oncology Fellow at UNC School of Medicine, shared a post by FlorezLab, adding:
“Incredible work by incoming Duaa Kanan at ASCO25. Her poster highlights a structure-based AI pipeline for identifying novel NSCLC therapies via FDA-approved and investigational drug repurposing.
Target: USP21, implicated in chemo resistance
Screened 687 molecules → 150 hits → 10 top leads via MD simulations
Translational potential in accelerating precision therapy for lung cancerA proud showing from FlorezLab.”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 6, 2025, 01:10
Jun 5, 2025, 15:47
Jun 5, 2025, 15:44
Jun 5, 2025, 15:07